Stacatto alprazolam: Preliminary Phase IIa data

Preliminary data from a double-blind, U.S. Phase IIa trial in 40 patients showed that AZ-002 missed its 2 primary endpoints of significantly reducing the incidence and duration of a doxapram-induced p...